Is vitamin E supplementation effective in reducing mortality related to cardiovascular events in people with type 2 diabetes mellitus? A systematic review
Authors:
Open Access
- 27 June 2016
- journal article
- review article
- Published by Elsevier in IJC Metabolic & Endocrine
- Vol. 12, 42-45
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The Use of Complementary and Alternative Medicine in Hospitalized Patients with Type 2 Diabetes Mellitus in IsraelThe Journal of Alternative and Complementary Medicine, 2015
- Patient selection and vitamin E treatment in diabetes mellitusExpert Review of Cardiovascular Therapy, 2013
- Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus — natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literatureEuropean Journal of Internal Medicine, 2012
- Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotypeAtherosclerosis, 2011
- Vitamin E Reduces Cardiovascular Disease in Individuals with Diabetes Mellitus and the Haptoglobin 2-2 GenotypePharmacogenomics, 2010
- Projecting the Future Diabetes Population Size and Related Costs for the U.S.Diabetes Care, 2009
- Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 GenotypeArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Vitamin E increases the risk of developing heart failure after myocardial infarction: results from the GISSI-Prevenzione trialJournal of Cardiovascular Medicine, 2006
- Vitamin E in the Primary Prevention of Cardiovascular Disease and CancerJAMA, 2005